Paediatric posterior reversible encephalopathy syndrome: a review of aetiologies, clinical and radiological spectrum, pathophysiology, diagnostic criteria and management
DOI:
https://doi.org/10.18203/2349-3291.ijcp20262985Keywords:
PRES, Diagnosis, Genetics, ManagementAbstract
Posterior reversible encephalopathy syndrome (PRES) is a rare clinico-radiological syndrome postulated to be due to disturbed cerebral autoregulation characterized by acute onset seizures, altered sensorium, headache, visual disturbances, and typical neuroimaging findings of vasogenic oedema in parietooccipital white matter. Although originally described in adults, PRES is increasingly recognized in children, particularly in association with renal disease, hypertension, autoimmune disorders, malignancy, chemotherapy, transplantation, infections, and immune-mediated conditions. Paediatric PRES differs from adult PRES in having a higher frequency of atypical imaging findings involving brainstem, spinal cord, basal ganglia; and broader etiological diversity. Advances in neuroimaging, molecular biology, and endothelial dysfunction research have improved understanding of disease mechanisms. However, diagnostic criteria remain largely clinico-radiological. This review summarizes current evidence regarding diagnosis, typical and atypical radiological findings, aetiologies, tertiary-care experiences, pathophysiological mechanisms, emerging genetic associations, and an algorithmic approach to management.
References
Ganzevoort W, Boterbloem K, van der Post J, Bleker O. 'Blindness out of the womb', a historical account of the first report of posterior reversible encephalopathy syndrome (PRES): choose your title well or your findings will be neglected. BJOG. 2020;127(1):37-8.
Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334(8):494-500.
Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: utility of FLAIR imaging in the detection of cortical and subcortical lesions. Am J Neuroradiol. 2000;21:1199-206.
Sharma S, Gupta R, Sehgal R, Aggarwal KC. Atypical presentation of posterior reversible encephalopathy: in a child with bilateral grade IV vesicoureteric reflux. J Trop Pediatr. 2014;60(4):331-3.
Thavamani A, Umapathi KK, Puliyel M, Super D, Allareddy V, Ghori A. Epidemiology, Comorbidities, and Outcomes of Posterior Reversible Encephalopathy Syndrome in Children in the United States. Pediatr Neurol. 2020;103:21-6.
He M, Gillespie A. Posterior Reversible Encephalopathy Syndrome in Chronic Kidney Disease: Incidence, Outcomes, and Risk Factors in a National Cohort. Kidney Med. 2025;7(7):101022.
Orlando C, Milani GP, Simonetti GD, Goeggel Simonetti B, Lava SAG, Wyttenbach R, et al. Posterior reversible leukoencephalopathy syndrome associated with acute postinfectious glomerulonephritis: systematic review. Pediatr Nephrol. 2022;37(4):833-41.
Yamada A, Atsumi M, Tashiro A, Hiraiwa T, Ueda N. Recurrent posterior reversible encephalopathy syndrome in nephrotic syndrome: case report and review of the literature. Clin Nephrol. 2012;78(5):406-11.
Youssef D, Fawzy F. Posterior reversible encephalopathy syndrome in a child with steroid sensitive nephrotic syndrome. Arab J Nephrol Transplant. 2012;5(3):163-6.
Zhang Y, Zhou J, Chen Y. Posterior reversible encephalopathy syndrome in a child with steroid-resistant nephrotic syndrome: a case report and review of literature. Int J Clin Exp Pathol. 2014;7(7):4433-7.
Karpman D, Loos S, Tati R, Arvidsson I. Haemolytic Uraemic Syndrome. J Intern Med. 2017;281:123-48.
Tonkovic U, Bogicevic M, Manzar A, Andrejic N, Sic A, Atanaskovic M, et al. Neurological Manifestations of Hemolytic Uremic Syndrome: A Comprehensive Review. Brain Sci. 2025;15(7):717.
Manadan A, Kambhatla S, Gauto-Mariotti E, Okoli C, Block JA. Rheumatic diseases associated with posterior reversible encephalopathy syndrome. J Clin Rheumatol. 2021;27:4.
Ramanathan S, Subramani V, Kembhavi S, Prasad M, Roy Moulik N, Dhamne C, et al. Clinical features, predictors and outcome of posterior reversible encephalopathy syndrome (PRES) in children with hematolymphoid malignancies. Childs Nerv Syst. 2022;38(9):1689-98.
Teive HA, Brandi IV, Camargo CH, Bittencourt MA, Bonfim CM, Friedrich ML, et al. Reversible posterior leucoencephalopathy syndrome associated with bone marrow transplantation. Arq Neuropsiquiatr. 2001;59(3-B):784-9.
Kaur G, Ashraf I, Peck MM, Maram R, Mohamed A, Crespo DO, et al. Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome. Cureus. 2020;12(10):e11163.
How J, Blattner M, Fowler S, Wang-Gillam A, Schindler SE. Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature. Neurologist. 2016;21(6):112-7.
Wake K, Imataka G, Ohnishi T, Kikuchi J, Hoshiyama E, Ono K, et al. A Case-Study of a Child with Reversible Posterior Leukoencephalopathy Syndrome (RPLS) Associated with Severe Burns throughout the Body. Iran J Public Health. 2020;49(7):1390-1.
He X, Shi D, Long C, Yang J, Tian J. Posterior reversible encephalopathy syndrome in a child after burns: A case report and literature review. SAGE Open Med Case Rep. 2023;11:2050313X231157988.
Barba L, Carrubba C, Spindler K, Weise CM, Sachs T, Foschi M, et al. Posterior reversible encephalopathy syndrome associated with antibiotic therapy: a case report and systematic review. Neurol Sci. 2024;45(9):4151-9.
Aydin K, Elmas S, Guzes EA. Reversible posterior leukoencephalopathy and Adie's pupil after measles vaccination. J Child Neurol. 2006;21(6):525-7.
Srichawla BS, Fang T, Kipkorir V, Garcia-Dominguez MA. Reversible cerebral vasoconstriction syndrome and posterior reversible encephalopathy syndrome following vaccination: analysis of the VAERS database and systematic review. Ann Med Surg (Lond). 2023;86(3):1251-60.
Sano H, Yamazaki T, Kudo E, Hatakeyama K, Ito T. Posterior reversible encephalopathy syndrome associated with mild COVID-19 infection in a 9-year-old child: A case report and literature review. IDCases. 2023;31:e01699.
Palliyaguru T, Ruwanpathirana P, Aravinthan M, Priyankara D, Weeratunga P. Posterior reversible encephalopathy syndrome in severe leptospirosis: A case report. IDCases. 2025;41:e02330.
Christofidis C, Anastasiou A, Krasnikova E, Mandros C, Potolidis E. Posterior reversible encephalopathy syndrome as a complication of bacterial meningitis. Hippokratia. 2019;23(3):131-4.
Lee DJ, Kim JS. Rotavirus Infection-Associated Posterior Reversible encephalopathy Syndrome. Ann Child Neurol. 2019;27(2):60-2.
Ito Y, Toyama K, Honda A, Nakazaki K, Arai S, Kurokawa M. Posterior reversible encephalopathy syndrome concurrent with human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation. J Infect Chemother. 2019;26(2):265-8.
Chen TH. Childhood Posterior Reversible Encephalopathy Syndrome: Clinicoradiological Characteristics, Managements, and Outcome. Front Pediatr. 2020;8:585.
Mani SH, Shivaprasad SM, Umesh L. A rare presentation of lupus nephritis flare up with posterior reversible leucoencephalopathy. J Clin Diagn Res. 2016;10:4.
Bhangu JK, Javed K, Manshahia PK, Nahar S, Kanda S, Chatha U, et al. The Association of Hypertension With Posterior Reversible Encephalopathy Syndrome in Systemic Lupus Erythematosus Patients: A Systematic Review. Cureus. 2023;15(12):e50620.
Radiopaedia. Posterior reversible encephalopathy syndrome. 2026. Available at: https://radiopaedia. org/articles/posterior-reversible-encephalopathy-syndrome-1. Accessed on 06 July 2026.
Bartynski W, Boardman J. Distinct Imaging Patterns and Lesion Distribution in Posterior Reversible Encephalopathy Syndrome. AJNR Am J Neuroradiol. 2007;28(7):1320-7.
Kaufmann J, Buecke P, Meinel T, Beyeler M, Scutelnic A, Kaesmacher J, et al. Frequency of ischaemic stroke and intracranial haemorrhage in patients with reversible cerebral vasoconstriction syndrome (RCVS) and posterior reversible encephalopathy syndrome (PRES) - A systematic review. Eur J Neurol. 2024;31(5):e16246.
Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14:914-25.
Chardain A, Mesnage V, Alamowitch S, Bourdain F, Crozier S, Lenglet T, et al. Posterior reversible encephalopathy syndrome (PRES) and hypomagnesemia: a frequent association? Rev Neurol. 2016;172(6–7):384-8.
Gao B, Yu BX, Li RS, Zhang G, Xie HZ, Liu FL, et al. Cytotoxic edema in posterior reversible encephalopathy syndrome: correlation of MRI features with serum albumin levels. AJNR Am J Neuroradiol. 2015;36(10):1884-9.
Largeau B, Bergeron S, Auger F, Salmon Gandonnière C, Jonville-Béra AP, Ehrmann S, et al. Experimental Models of Posterior Reversible Encephalopathy Syndrome: A Review From Pathophysiology to Therapeutic Targets. Stroke. 2024;55(2):484-93.
ClinicalTrial.Gov. The Arginine Vasopressin aXis as a Potential Therapeutic Target for Posterior REverSible Encephalopathy SyndromE (XPRESSE). 2022. Available at: https://clinicaltrials.gov/ct2/ show/NCT04950270. Accessed on 15 June 2026.
Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017;264(8):1608-16.
Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc. 2010;85(5):427-32.
Gupta V, Bhatia V, Khandelwal N, Singh P, Singhi P. Imaging Findings in Pediatric Posterior Reversible Encephalopathy Syndrome (PRES): 5 Years of Experience From a Tertiary Care Center in India. J Child Neurol. 2016;31(9):1166-73.
Gaddam S, Kodandapani R, Mani N, Jayaraman D, Abirami BN. Posterior reversible encephalopathy syndrome in immunocompromised children - A single-center study from South India. J Neurosci Rural Pract. 2024;15(2):365-9.
Emeksiz S, Kutlu NO, Çaksen H, Alkan G, Yıkmaz HŞ, Tokgöz H. Posterior reversible encephalopathy syndrome in children: a case series. Turk Pediatri Ars. 2016;51(4):217-20.
de Laat P, Te Winkel ML, Devos AS, Catsman-Berrevoets CE, Pieters R, van den Heuvel-Eibrink MM. Posterior reversible encephalopathy syndrome in childhood cancer. Ann Oncol. 2011;22(2):472-8.
Srichawla BS, Kaur T, Singh H. Corticosteroids in posterior reversible encephalopathy syndrome: Friend or foe? A systematic review. World J Clin Cases. 2025;13(12):98768.
Meyer M, Niemöller U, Stein T, Schmetsdorf S, Arnold A, El-Sheik M, et al. Positive Effect of Steroids in Posterior Reversible Encephalopathy Syndrome. Case Rep Neurol. 2019;11(2):173-7.
Gavrilovici C, Miron I, Voroneanu L, Bădărau S, Stârcea M. Posterior reversible encephalopathy syndrome in children with kidney disease. Int Urol Nephrol. 2017;49(10):1793-800.
Triplett JD, Kutlubaev MA, Kermode AG, Hardy T. Posterior reversible encephalopathy syndrome (PRES): diagnosis and management. Pract Neurol. BMJ Publishing Group Ltd. 2022.
Hinduja A. Posterior reversible encephalopathy syndrome: clinical features and outcome. Front Neurol. 2020;11:71.
Gewirtz AN, Gao V, Parauda SC, Robbins MS. Posterior reversible encephalopathy syndrome. Curr Pain Headache Rep. 2021;25:19.
Nada MG, Libda YI, Gohary MM, Dessouky R. Pediatric posterior reversible encephalopathy syndrome: Can MR imaging features predict outcomes in non-oncologic patients? Eur J Radiol. 2024;170:111214.
Downloads
Published
How to Cite
Issue
Section
